The World Health Organization (WHO) said that Ebola virus infection in West Africa continues to constitute a Public Health Emergency of International Concern (PHEIC), largely due to the potential for transmission of the virus from survivors and convalescent populations, according to a Dec 18 statement.
The NIH sees its biggest boost in 12 years, and other public health initiatives benefit, too.
A live attenuated influenza vaccine (LAIV) candidate for H7N9 avian flu produced a good immune response and was shown safe in a phase 1 human trial, researchers from Russia and the World Health Organization (WHO) reported yesterday in The Lancet Infectious Diseases.
Experts recommend a separate entity within the WHO to handle outbreaks and emergencies.
The group of 28 experts continues to offer Ebola vaccine guidance and says its concept could be used in other outbreaks.
NewLink Genetics today announced that the federal government has exercised an $18 million option to ramp up the production of its experimental Ebola vaccine VSV-EBOV, according to a statement from the company. The company has licensed the vaccine from the Public Health Agency of Canada, the developer of the vaccine, which is furthest along in clinical studies in the West African outbreak region.
Saudi Arabia's health ministry today announced two new MERS-CoV cases, both of them from Riyadh, an area that over the past several weeks has experienced a spate of hospital-linked cases.
The WHO announces a unified program for health emergencies, vaccine support, and other reforms.
For the third day in a row South Korea reported no new MERS-CoV cases, but its health ministry today reported one more death, involving an 81-year-old woman who had a stoke before she was diagnosed, the Korea Times reported today. The woman was exposed to the virus while at Samsung Medical Center in Seoul.
An international research group today warned that climate change could erode 50 years' of public health gains, but addressing the problem now presents a global health opportunity, according to a report today in The Lancet.
